Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ruxolitinib for Adult T-Cell Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01712659
Recruitment Status : Recruiting
First Posted : October 23, 2012
Last Update Posted : March 16, 2021
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )